The partners are preparing for commercialization of the lung cancer drug limertinib as they await an approval decision from China’s National Drug Administration.

Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of ...

Patient recruitment is a critical and often challenging aspect of clinical trials, particularly for biopharmaceutical ...

Rebekah's father passed on his passion for science and problem solving to her and much her of childhood was spent doing fun ...

The proceeds of the financing will support the development of LoQus23’s lead candidate, a small molecule inhibitor that is ...

SK Group’s contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its ...

The company, a provider of drug containment and delivery solutions, will introduce its expanded Vertiva 10mL on-body delivery system. The company says this new platform is specifically designed to ...